Skip to main content
Top
Gepubliceerd in: Tijdschrift voor Kindergeneeskunde 2/2004

01-04-2004 | Artikelen

Genetische factoren van de gastheer in infecties met Neisseria meningitidis

Auteurs: M. Emonts, P. W. M. Hermans, R. de Groot, J. A. Hazelzet

Gepubliceerd in: Tijdschrift voor Kindergeneeskunde | Uitgave 2/2004

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Neisseria meningitidis is verantwoordelijk voor infectie met een wisselende klinische presentatie. Het spectrum reikt van meningitis tot sepsis en septische shock. Tot voor kort was niet duidelijk wat het verschil in ernst en gevoeligheid voor infectie veroorzaakte. Verschil in serotype van de bacterie en omgevingsfactoren spelen een rol. Recentelijk is duidelijk geworden dat ook genetische variabiliteit van de gastheer bijdraagt aan het verschil in de gevoeligheid voor, ernst van en outcome van infectie. De genen die hierbij een rol spelen, coderen voor eiwitten die betrokken zijn bij een van de drie cascades die geactiveerd worden tijdens infectie. Deze drie cascades betreffen het complementsysteem, de ontstekingsreactie, en het stollings- en fibrinolytisch systeem. We geven een overzicht van de genetische variaties die bestudeerd zijn in patiënten met meningokokkeninfecties en de problemen die optreden bij de interpretatie van de resultaten en het vergelijken van onderzoeken. Slechts van enkele polymorfismen, waaronder de pai1 4G/5G-variant, is in een onafhankelijk onderzoek de associatie met outcome van ziekte bevestigd.
Literatuur
go back to reference Rich RR, Fleisher TA, Schroeder HW Jr, eds. Clinical immunology, principles and practice, 2nd ed. St. Louis: Mosby, 2001. Rich RR, Fleisher TA, Schroeder HW Jr, eds. Clinical immunology, principles and practice, 2nd ed. St. Louis: Mosby, 2001.
go back to reference Kornelisse RF, Groot R de, Neijens HJ. Bacterial meningitis: mechanisms of disease and therapy. Eur J Pediatr 1995; 154(2):85-96.CrossRefPubMed Kornelisse RF, Groot R de, Neijens HJ. Bacterial meningitis: mechanisms of disease and therapy. Eur J Pediatr 1995; 154(2):85-96.CrossRefPubMed
go back to reference Kleijn ED de, Hazelzet JA, Kornelisse RF, Groot R de. Pathophysiology of meningococcal sepsis in children. Eur J Pediatr 1998;157(11):869-80.CrossRefPubMed Kleijn ED de, Hazelzet JA, Kornelisse RF, Groot R de. Pathophysiology of meningococcal sepsis in children. Eur J Pediatr 1998;157(11):869-80.CrossRefPubMed
go back to reference Read RC, Cannings C, Naylor SC, et al. Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease. Ann Intern Med 2003;138(7):534-41.PubMed Read RC, Cannings C, Naylor SC, et al. Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease. Ann Intern Med 2003;138(7):534-41.PubMed
go back to reference Haralambous E, Weiss H, Radalowicz A, et al. Sibling familial risk ratio of meningococcal disease in UK Caucasians. Epidemiol Infect 2003;130(3):413-8.PubMed Haralambous E, Weiss H, Radalowicz A, et al. Sibling familial risk ratio of meningococcal disease in UK Caucasians. Epidemiol Infect 2003;130(3):413-8.PubMed
go back to reference Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002;14(1):103-10.CrossRefPubMed Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002;14(1):103-10.CrossRefPubMed
go back to reference Read RC, Pullin J, Gregory S, et al. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 2001;184 (5):640-2.CrossRefPubMed Read RC, Pullin J, Gregory S, et al. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 2001;184 (5):640-2.CrossRefPubMed
go back to reference Smirnova I, Hamblin MT, McBride C, et al. Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics 2001;158(4):1657-64.PubMed Smirnova I, Hamblin MT, McBride C, et al. Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics 2001;158(4):1657-64.PubMed
go back to reference Smirnova I, Mann N, Dols A, et al. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci USA 2003;100(10):6075-80.CrossRefPubMed Smirnova I, Mann N, Dols A, et al. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci USA 2003;100(10):6075-80.CrossRefPubMed
go back to reference Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86(4):1343-6.CrossRefPubMed Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86(4):1343-6.CrossRefPubMed
go back to reference Harding D, Baines PB, Brull D, et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 2002;165(8):1103-6.PubMed Harding D, Baines PB, Brull D, et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 2002;165(8):1103-6.PubMed
go back to reference Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995;92(6):1387-8.PubMed Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995;92(6):1387-8.PubMed
go back to reference Von Depka M, Czwalinna A, Wermes C, et al. The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. Thromb Haemost 2003;89(5):847-52. Von Depka M, Czwalinna A, Wermes C, et al. The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. Thromb Haemost 2003;89(5):847-52.
go back to reference Hazelzet JA, Groot R de, Mierlo G van, et al. Complement activation in relation to capillary leakage in children with septic shock and purpura. Infect Immun 1998;66(11):5350-6.PubMed Hazelzet JA, Groot R de, Mierlo G van, et al. Complement activation in relation to capillary leakage in children with septic shock and purpura. Infect Immun 1998;66(11):5350-6.PubMed
go back to reference Hibberd ML, Summerfield JA, Levin M. Variation in the Mannose Binding Lectin (MBL) gene and susceptibility to sepsis. Sepsis 2001;4(3):201-7.CrossRef Hibberd ML, Summerfield JA, Levin M. Variation in the Mannose Binding Lectin (MBL) gene and susceptibility to sepsis. Sepsis 2001;4(3):201-7.CrossRef
go back to reference Madsen HO, Garred P, Kurtzhals JA, et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994;40(1): 37-44.CrossRefPubMed Madsen HO, Garred P, Kurtzhals JA, et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994;40(1): 37-44.CrossRefPubMed
go back to reference Hibberd ML, Sumiya M, Summerfield JA, et al. Meningococcal Research Group. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet 1999;353(9158):1049-53.CrossRefPubMed Hibberd ML, Sumiya M, Summerfield JA, et al. Meningococcal Research Group. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet 1999;353(9158):1049-53.CrossRefPubMed
go back to reference Spath PJ, Sjoholm AG, Fredrikson GN, et al. Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n). Clin Exp Immunol 1999;118(2):278-84.CrossRefPubMed Spath PJ, Sjoholm AG, Fredrikson GN, et al. Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n). Clin Exp Immunol 1999;118(2):278-84.CrossRefPubMed
go back to reference Westberg J, Fredrikson GN, Truedsson L, et al. Sequence-based analysis of properdin deficiency: identification of point mutations in two phenotypic forms of an X-linked immunodeficiency. Genomics 1995;29(1):1-8.CrossRefPubMed Westberg J, Fredrikson GN, Truedsson L, et al. Sequence-based analysis of properdin deficiency: identification of point mutations in two phenotypic forms of an X-linked immunodeficiency. Genomics 1995;29(1):1-8.CrossRefPubMed
go back to reference Bogaard R van den, Fijen CA, Schipper MG, et al. Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies. Eur J Hum Genet 2000;8(7):513-8.CrossRefPubMed Bogaard R van den, Fijen CA, Schipper MG, et al. Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies. Eur J Hum Genet 2000;8(7):513-8.CrossRefPubMed
go back to reference Fredrikson GN, Gullstrand B, Westberg J, et al. Investigation of properdin expression in monocytes from properdin deficient individuals by intracellular staining and mRNA analysis. Exp Clin Immunogenet 1997;14:61. Fredrikson GN, Gullstrand B, Westberg J, et al. Investigation of properdin expression in monocytes from properdin deficient individuals by intracellular staining and mRNA analysis. Exp Clin Immunogenet 1997;14:61.
go back to reference Fredrikson GN, Westberg J, Kuijper EJ, et al. Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange. J Immunol 1996;157(8):3666-71.PubMed Fredrikson GN, Westberg J, Kuijper EJ, et al. Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange. J Immunol 1996;157(8):3666-71.PubMed
go back to reference Fijen CA, Kuijper EJ, Bulte MT te, et al. Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis 1999;28(1):98-105.CrossRefPubMed Fijen CA, Kuijper EJ, Bulte MT te, et al. Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis 1999;28(1):98-105.CrossRefPubMed
go back to reference Densen P, Weiler JM, Griffiss JM, Hoffmann LG. Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination. N Engl J Med 1987;316(15):922-6.PubMedCrossRef Densen P, Weiler JM, Griffiss JM, Hoffmann LG. Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination. N Engl J Med 1987;316(15):922-6.PubMedCrossRef
go back to reference Hazelzet JA, Risseeuw-Appel IM, Kornelisse RF, et al. Age-related differences in outcome and severity of DIC in children with septic shock and purpura. Thromb Haemost 1996;76 (6):932-8.PubMed Hazelzet JA, Risseeuw-Appel IM, Kornelisse RF, et al. Age-related differences in outcome and severity of DIC in children with septic shock and purpura. Thromb Haemost 1996;76 (6):932-8.PubMed
go back to reference Eriksson P, Kallin B, Hooft FM van 't, et al. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995;92(6):1851-5.CrossRefPubMed Eriksson P, Kallin B, Hooft FM van 't, et al. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995;92(6):1851-5.CrossRefPubMed
go back to reference Kornelisse RF, Hazelzet JA, Savelkoul HF, et al. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis 1996;173 (5):1148-56.PubMed Kornelisse RF, Hazelzet JA, Savelkoul HF, et al. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis 1996;173 (5):1148-56.PubMed
go back to reference Hermans PW, Hibberd ML, Booy R, et al. Meningococcal Research Group. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Lancet 1999;354(9178):556-60.CrossRefPubMed Hermans PW, Hibberd ML, Booy R, et al. Meningococcal Research Group. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Lancet 1999;354(9178):556-60.CrossRefPubMed
go back to reference Westendorp RG, Hottenga JJ, Slagboom PE. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 1999;354(9178):561-3.CrossRefPubMed Westendorp RG, Hottenga JJ, Slagboom PE. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 1999;354(9178):561-3.CrossRefPubMed
go back to reference Haralambous E, Hibberd M, Ninis N, et al. The role of the functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity and outcome of meningococcal disease in Caucasian children. Crit Care Med 2003;31(12):2788-93.CrossRefPubMed Haralambous E, Hibberd M, Ninis N, et al. The role of the functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity and outcome of meningococcal disease in Caucasian children. Crit Care Med 2003;31(12):2788-93.CrossRefPubMed
go back to reference Kondaveeti S, Hibberd ML, Booy R, et al. Effect of the Factor V Leiden mutation on the severity of meningococcal disease. Pediatr Infect Dis J 1999;18(10):893-6.CrossRefPubMed Kondaveeti S, Hibberd ML, Booy R, et al. Effect of the Factor V Leiden mutation on the severity of meningococcal disease. Pediatr Infect Dis J 1999;18(10):893-6.CrossRefPubMed
go back to reference Kondaveeti S, Hibberd ML, Levin M. The insertion/deletion polymorphism in the t-PA gene does not significantly affect outcome of meningococcal disease. Thromb Haemost 1999; 82(1):161-2.PubMed Kondaveeti S, Hibberd ML, Levin M. The insertion/deletion polymorphism in the t-PA gene does not significantly affect outcome of meningococcal disease. Thromb Haemost 1999; 82(1):161-2.PubMed
go back to reference Hazelzet JA, Kleijn ED de, Groot R de. Endothelial protein C activation in meningococcal sepsis. N Engl J Med 2001; 345(24):1776-7.CrossRefPubMed Hazelzet JA, Kleijn ED de, Groot R de. Endothelial protein C activation in meningococcal sepsis. N Engl J Med 2001; 345(24):1776-7.CrossRefPubMed
go back to reference Kleijn ED de, Groot R de, Hack CE, et al. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: A randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 2003;31(6):1839-47.CrossRefPubMed Kleijn ED de, Groot R de, Hack CE, et al. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: A randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 2003;31(6):1839-47.CrossRefPubMed
go back to reference Yuksel M, Okajima K, Uchiba M, et al. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemost 2002;88(2):267-73.PubMed Yuksel M, Okajima K, Uchiba M, et al. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemost 2002;88(2):267-73.PubMed
go back to reference Hackett SJ, Thomson AP, Hart CA. Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol 2001;50(10):847-59.PubMed Hackett SJ, Thomson AP, Hart CA. Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol 2001;50(10):847-59.PubMed
go back to reference Westendorp RG, Langermans JA, Bel CE de, et al. Release of tumor necrosis factor: an innate host characteristic that may contribute to the outcome of meningococcal disease. J Infect Dis 1995;171(4):1057-60.PubMed Westendorp RG, Langermans JA, Bel CE de, et al. Release of tumor necrosis factor: an innate host characteristic that may contribute to the outcome of meningococcal disease. J Infect Dis 1995;171(4):1057-60.PubMed
go back to reference Westendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349(9046):170-3.CrossRefPubMed Westendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349(9046):170-3.CrossRefPubMed
go back to reference Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996;174(4):878-80.PubMed Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996;174(4):878-80.PubMed
go back to reference Westendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production in meningococcal disease. Lancet 1997;349(9069):1912-3.CrossRefPubMed Westendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production in meningococcal disease. Lancet 1997;349(9069):1912-3.CrossRefPubMed
go back to reference Booy R, Nadel S, Hibberd M, et al. Genetic influence on cytokine production in meningococcal disease. Lancet 1997;349 (9059):1176.CrossRefPubMed Booy R, Nadel S, Hibberd M, et al. Genetic influence on cytokine production in meningococcal disease. Lancet 1997;349 (9059):1176.CrossRefPubMed
go back to reference Huizinga TW, Westendorp RG, Bollen EL, et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997;72(2):149-53.CrossRefPubMed Huizinga TW, Westendorp RG, Bollen EL, et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997;72(2):149-53.CrossRefPubMed
go back to reference Uglialoro AM, Turbay D, Pesavento PA, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998;52(4):359-67.CrossRefPubMed Uglialoro AM, Turbay D, Pesavento PA, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998;52(4):359-67.CrossRefPubMed
go back to reference Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91(4):403-4.CrossRefPubMed Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91(4):403-4.CrossRefPubMed
go back to reference Read RC, Camp NJ, di Giovine FS, et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 2000;182(5):1557-60.CrossRefPubMed Read RC, Camp NJ, di Giovine FS, et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 2000;182(5):1557-60.CrossRefPubMed
go back to reference Clay FE, Tarlow JK, Cork MJ, et al. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Hum Genet 1996;97(6):723-6.CrossRefPubMed Clay FE, Tarlow JK, Cork MJ, et al. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Hum Genet 1996;97(6):723-6.CrossRefPubMed
go back to reference Carrol ED, Mobbs KJ, Thomson AP, Hart CA. Variable number tandem repeat polymorphism of the interleukin-1 receptor antagonist gene in meningococcal disease. Clin Infect Dis 2002;35(4):495-7.CrossRefPubMed Carrol ED, Mobbs KJ, Thomson AP, Hart CA. Variable number tandem repeat polymorphism of the interleukin-1 receptor antagonist gene in meningococcal disease. Clin Infect Dis 2002;35(4):495-7.CrossRefPubMed
go back to reference Balding J, Livingstone WJ, Healy M, et al. G to C transition in the promotor region of the IL6 gene is associated with disease outcome in meningococcal sepsis [abstract]. XVIII International Society on Thrombosis and Haemostasis. Paris, 2001, p. P1065. Balding J, Livingstone WJ, Healy M, et al. G to C transition in the promotor region of the IL6 gene is associated with disease outcome in meningococcal sepsis [abstract]. XVIII International Society on Thrombosis and Haemostasis. Paris, 2001, p. P1065.
go back to reference Schluter B, Raufhake C, Erren M, et al. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 2002;30(1):32-7.CrossRefPubMed Schluter B, Raufhake C, Erren M, et al. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 2002;30(1):32-7.CrossRefPubMed
go back to reference Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275(24):18138-44.CrossRefPubMed Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275(24):18138-44.CrossRefPubMed
go back to reference Deventer SJ van, Buller HR, Cate JW ten, et al. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990;76(12):2520-6.PubMed Deventer SJ van, Buller HR, Cate JW ten, et al. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990;76(12):2520-6.PubMed
go back to reference Eskdale J, Gallagher G, Verweij CL, et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998;95(16):9465-70.CrossRefPubMed Eskdale J, Gallagher G, Verweij CL, et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998;95(16):9465-70.CrossRefPubMed
go back to reference Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24(1):1-8.PubMed Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24(1):1-8.PubMed
go back to reference Gibson AW, Edberg JC, Wu J, et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001;166(6):3915-22.PubMed Gibson AW, Edberg JC, Wu J, et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001;166(6):3915-22.PubMed
go back to reference Pol WL van der, Huizinga TW, Vidarsson G, et al. Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease. J Infect Dis 2001;184(12):1548-55.CrossRefPubMed Pol WL van der, Huizinga TW, Vidarsson G, et al. Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease. J Infect Dis 2001;184(12):1548-55.CrossRefPubMed
go back to reference Domingo P, Muniz-Diaz E, Baraldes MA, et al. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am J Med 2002; 112(1):19-25.CrossRefPubMed Domingo P, Muniz-Diaz E, Baraldes MA, et al. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am J Med 2002; 112(1):19-25.CrossRefPubMed
go back to reference Bredius RG, Derkx BH, Fijen CA, et al. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994;170(4):848-53.PubMed Bredius RG, Derkx BH, Fijen CA, et al. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994;170(4):848-53.PubMed
go back to reference Smith I, Vedeler C, Halstensen A. FcgammaRIIa and FcgammaRIIIb polymorphisms were not associated with meningococcal disease in Western Norway. Epidemiol Infect 2003; 130(2):193-9.CrossRefPubMed Smith I, Vedeler C, Halstensen A. FcgammaRIIa and FcgammaRIIIb polymorphisms were not associated with meningococcal disease in Western Norway. Epidemiol Infect 2003; 130(2):193-9.CrossRefPubMed
go back to reference Platonov AE, Kuijper EJ, Vershinina IV, et al. Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals. Clin Exp Immunol 1998;111(1):97-101.CrossRefPubMed Platonov AE, Kuijper EJ, Vershinina IV, et al. Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals. Clin Exp Immunol 1998;111(1):97-101.CrossRefPubMed
go back to reference Fijen CA, Bredius RG, Kuijper EJ. Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med 1993;119(7 Pt 1):636.PubMed Fijen CA, Bredius RG, Kuijper EJ. Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med 1993;119(7 Pt 1):636.PubMed
go back to reference Pol WL van der, Jansen MD, Sluiter WJ, et al. Evidence for non-random distribution of Fcgamma receptor genotype combinations. Immunogenetics 2003;55(4):240-6.CrossRefPubMed Pol WL van der, Jansen MD, Sluiter WJ, et al. Evidence for non-random distribution of Fcgamma receptor genotype combinations. Immunogenetics 2003;55(4):240-6.CrossRefPubMed
go back to reference Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 1969;129(6):1327-48.CrossRefPubMed Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 1969;129(6):1327-48.CrossRefPubMed
go back to reference Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969;129(6):1307-26.CrossRefPubMed Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969;129(6):1307-26.CrossRefPubMed
go back to reference Griffiss JM, Bannatyne RM, Artenstein MS, Anglin CS. Recurrent meningococcal infection with an antigenically identical strain. JAMA 1974;229(1):68-70.CrossRefPubMed Griffiss JM, Bannatyne RM, Artenstein MS, Anglin CS. Recurrent meningococcal infection with an antigenically identical strain. JAMA 1974;229(1):68-70.CrossRefPubMed
go back to reference Borrow R. Update on meningococcal C conjugate vaccination programme in the UK. 21st meeting European Society for Paediatric Infectious Diseases. Giardini Naxos, 2003, p. 6. Borrow R. Update on meningococcal C conjugate vaccination programme in the UK. 21st meeting European Society for Paediatric Infectious Diseases. Giardini Naxos, 2003, p. 6.
go back to reference Dankert J, Ende A van der, Spanjaard L. Epidemiology of group C meningococcal disease in the Netherlands. 21st meeting European Society for Paediatric Infectious Diseases. Giardini Naxos, 2003, p. 7. Dankert J, Ende A van der, Spanjaard L. Epidemiology of group C meningococcal disease in the Netherlands. 21st meeting European Society for Paediatric Infectious Diseases. Giardini Naxos, 2003, p. 7.
go back to reference Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 1996;24(5):743-52.CrossRefPubMed Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 1996;24(5):743-52.CrossRefPubMed
go back to reference Kornelisse RF, Hazelzet JA, Hop WC, et al. Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin Infect Dis 1997;25(3):640-6.CrossRefPubMed Kornelisse RF, Hazelzet JA, Hop WC, et al. Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin Infect Dis 1997;25(3):640-6.CrossRefPubMed
go back to reference Lazarus R, Klimecki WT, Raby BA, et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 2003;81(1):85-91.CrossRefPubMed Lazarus R, Klimecki WT, Raby BA, et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 2003;81(1):85-91.CrossRefPubMed
Metagegevens
Titel
Genetische factoren van de gastheer in infecties met Neisseria meningitidis
Auteurs
M. Emonts
P. W. M. Hermans
R. de Groot
J. A. Hazelzet
Publicatiedatum
01-04-2004
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Kindergeneeskunde / Uitgave 2/2004
Print ISSN: 0376-7442
Elektronisch ISSN: 1875-6840
DOI
https://doi.org/10.1007/BF03061487

Andere artikelen Uitgave 2/2004

Tijdschrift voor Kindergeneeskunde 2/2004 Naar de uitgave